Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)-Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study.
暂无分享，去创建一个
P. Postmus | Keunchil Park | R. Dziadziuszko | A. Ardizzoni | B. Cho | Sang-We Kim | Cheng-Ta Yang | M. McKeage | G. de Castro | A. Bearz | U. Batra | V. Passos | S. Laurie | A. Bettini | Yvonne Y. Lau | Sarayut Lucien Geater | S. Orlov | R. Obermannova | K. Viraswami-Appanna | G. Borra | F. Kiertsman | Zhe Chen | Dong-Wang Kim